Advertisement
Screener

10x Genomics, Inc. (TXG) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Financing Cash Flow

10x Genomics, Inc. (TXG) reported Financing Cash Flow of -$5.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07

  • 10x Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.02M, a 14.37% decline year-over-year.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$8.42M, a 2094.55% decline year-over-year.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.24M, a 50.37% decline year-over-year.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $617.00K, a 295.51% increase year-over-year.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $6.80M, a 37.67% decline from fiscal 2024.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $10.91M, a 20.16% decline from fiscal 2023.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $13.67M, a 13.58% decline from fiscal 2022.
  • 10x Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $15.82M, a 55.19% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$3.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$5.40M
10-Q · filed 2026-08-07
-$3.16M
derived: sum of 3 quarters · filed 2026-08-07
-$2.54M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$8.42M
10-Q · filed 2026-05-08
-$6.17M
derived: sum of 2 quarters · filed 2026-05-08
-$5.56M
derived: sum of 3 quarters · filed 2026-05-08
-$2.04M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$2.86M
derived: sum of 2 quarters · filed 2026-02-13
$6.38M
derived: sum of 3 quarters · filed 2026-08-07
$6.80M
10-K · filed 2026-02-13
2025-09-30$617.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$4.14M
derived: sum of 2 quarters · filed 2026-08-07
$4.56M
10-Q · filed 2025-11-07
$9.08M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$3.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$3.94M
10-Q · filed 2026-08-07
$8.46M
derived: sum of 3 quarters · filed 2026-08-07
$8.62M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$422.00K
10-Q · filed 2026-05-08
$4.94M
derived: sum of 2 quarters · filed 2026-05-08
$5.09M
derived: sum of 3 quarters · filed 2026-05-08
$9.70M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$4.67M
derived: sum of 2 quarters · filed 2026-02-13
$9.28M
derived: sum of 3 quarters · filed 2026-02-13
$10.91M
10-K · filed 2026-02-13
2024-09-30$156.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$4.76M
derived: sum of 2 quarters · filed 2025-11-07
$6.40M
10-Q · filed 2025-11-07
$12.01M
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$6.24M
10-Q · filed 2025-08-08
$11.85M
derived: sum of 3 quarters · filed 2026-02-13
$16.23M
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31$1.64M
10-Q · filed 2025-05-09
$7.25M
derived: sum of 2 quarters · filed 2026-02-13
$11.63M
derived: sum of 3 quarters · filed 2026-02-13
$18.72M
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31$5.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$9.99M
derived: sum of 2 quarters · filed 2026-02-13
$17.08M
derived: sum of 3 quarters · filed 2026-02-13
$13.67M
10-K · filed 2026-02-13
2023-09-30$4.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$11.47M
derived: sum of 2 quarters · filed 2024-10-29
$8.06M
10-Q · filed 2024-10-29
$13.06M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$7.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$3.68M
10-Q · filed 2024-08-08
$8.68M
derived: sum of 3 quarters · filed 2025-02-13
$10.72M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$3.41M
10-Q · filed 2024-04-30
$1.59M
derived: sum of 2 quarters · filed 2025-02-13
$3.63M
derived: sum of 3 quarters · filed 2025-02-13
$9.99M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$7.04M
derived: sum of 2 quarters · filed 2025-02-13
$13.40M
derived: sum of 3 quarters · filed 2025-02-13
$15.82M
10-K · filed 2025-02-13
2022-09-30$2.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$8.40M
derived: sum of 2 quarters · filed 2023-11-03
$10.82M
10-Q · filed 2023-11-03
$19.72M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$6.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$8.78M
10-Q · filed 2023-08-04
$17.68M
derived: sum of 3 quarters · filed 2024-02-15
$24.36M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$2.42M
10-Q · filed 2023-05-04
$11.32M
derived: sum of 2 quarters · filed 2024-02-15
$18.00M
derived: sum of 3 quarters · filed 2024-02-15
$34.20M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$8.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$15.59M
derived: sum of 2 quarters · filed 2024-02-15
$31.78M
derived: sum of 3 quarters · filed 2024-02-15
$35.30M
10-K · filed 2024-02-15
2021-09-30$6.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$22.88M
derived: sum of 2 quarters · filed 2022-11-03
$26.39M
10-Q · filed 2022-11-03
$34.10M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$16.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$19.71M
10-Q · filed 2022-08-09
$27.42M
derived: sum of 3 quarters · filed 2023-02-16
$514.38M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$3.52M
10-Q · filed 2022-05-05
$11.22M
derived: sum of 2 quarters · filed 2023-02-16
$498.19M
derived: sum of 3 quarters · filed 2023-02-16
$506.24M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$7.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$494.67M
derived: sum of 2 quarters · filed 2023-02-16
$502.73M
derived: sum of 3 quarters · filed 2023-02-16
$468.91M
10-K · filed 2023-02-16
2020-09-30$486.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$495.02M
derived: sum of 2 quarters · filed 2021-11-05
$461.20M
10-Q · filed 2021-11-05
$460.09M
derived: sum of 4 quarters · filed 2022-02-18
2020-06-30$8.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$25.77M
10-Q · filed 2021-08-06
-$26.88M
derived: sum of 3 quarters · filed 2022-02-18
$388.76M
derived: sum of 4 quarters · filed 2022-02-18
2020-03-31-$33.82M
10-Q · filed 2021-05-07
-$34.93M
derived: sum of 2 quarters · filed 2022-02-18
$380.71M
derived: sum of 3 quarters · filed 2022-02-18
$379.85M
derived: sum of 4 quarters · filed 2022-02-18
2019-12-31-$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
$414.53M
derived: sum of 2 quarters · filed 2022-02-18
$413.67M
derived: sum of 3 quarters · filed 2022-02-18
$414.59M
10-K · filed 2022-02-18
2019-09-30$415.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$414.77M
derived: sum of 2 quarters · filed 2020-11-12
$415.70M
10-Q · filed 2020-11-12
$451.57M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$864.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$59.00K
10-Q · filed 2020-08-12
$35.94M
derived: sum of 3 quarters · filed 2021-02-26
2019-03-31$923.00K
10-Q · filed 2020-05-12
$36.80M
derived: sum of 2 quarters · filed 2021-02-26
2018-12-31$35.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$105.37M
10-K · filed 2021-02-26
2018-09-30$69.49M
10-Q · filed 2019-11-12
2017-12-31$20.58M
10-K · filed 2020-02-27